RICHARD STRATTON: Open Payments
NPI 1619402849 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,632 in 139 payments from 18 companies in 2025. Trend: 2023 $2,751 · 2024 $2,523 · 2025 $2,632
Food & beverage: $2,599Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $534 |
| Neurocrine BioSciences, Inc. | 13 | $329 |
| Otsuka America Pharmaceutical, Inc. | 17 | $305 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $261 |
| Vanda Pharmaceuticals Inc. | 13 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $180 |
| E.R. Squibb & Sons, L.L.C. | 8 | $154 |
| Janssen Pharmaceuticals, Inc | 5 | $125 |
| Teva Pharmaceuticals USA, Inc. | 5 | $120 |
| Supernus Pharmaceuticals, Inc. | 4 | $85 |
Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, FANAPT, TRINTELLIX, COBENFY, SPRAVATO.
Industry payments across NC — which companies pay providers there.
